Breaking News Bar

Business News and Information

Bag This Bargain Even Cheaper Than Director Coleman Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 12, Axsome Therapeutics Inc's Director, Mark Coleman, invested $29,075.00 into 500 shares of AXSM, for a cost per share of $58.15..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear